Stay updated on Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The PubMed publications note was updated to clarify that publications are automatically filled from PubMed and may not be about the study, and a new 'Revision: v3.3.2' label was added.
    Difference
    0.0%
    Check dated 2025-11-25T10:47:41.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Removed an administrative funding/update-status disclaimer from the page.
    Difference
    0.2%
    Check dated 2025-11-18T06:55:41.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The two Taiwan study locations were updated from 'Tainan City, Taiwan, 704' and 'Tainan City, Taiwan, 736' to 'Tainan, Taiwan, 704' and 'Tainan, Taiwan, 736' in the Locations section.
    Difference
    0.0%
    Check dated 2025-11-11T02:27:14.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Observed minor UI updates and a recent update timestamp, with no changes to core study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T21:03:07.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    - Added a government notice about funding and operating status, and a new v3.2.0 revision tag. - Removed the previous v3.1.0 revision tag.
    Difference
    2%
    Check dated 2025-10-06T05:25:15.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Version tag updated from v3.0.2 to v3.1.0; no substantive content changes.
    Difference
    0.1%
    Check dated 2025-09-29T03:04:35.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial page.